Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis
Abstract Corticosteroids may produce a paradoxical worsening of myasthenia gravis (MG) symptoms within the first weeks of treatment. We therefore wanted to assess the hypothesis that a prior infusion of intravenous immunoglobulin (IVIG) may have a protective effect. Our primary objectives were to sh...
Saved in:
Main Authors: | Laura Díez-Porras, Christian Homedes, Maria Antonia Alberti, Valentina Vélez-Santamaría, Carlos Casasnovas |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/242967baf4764d01abfbcf9b81b6a5e2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profound olfactory dysfunction in myasthenia gravis.
by: Fidias E Leon-Sarmiento, et al.
Published: (2012) -
Fetal Surveillance in Pregnancies with Myasthenia Gravis
by: Brîndușa Ana Cimpoca-Raptis, et al.
Published: (2021) -
PLASMAPHERESIS IN THE TREATMENT OF MYASTHENIA GRAVIS: OUTCOME AND COMPLICATIONS
by: Maryam Abbas, et al.
Published: (2021) -
Frontalis sling procedure for ocular myasthenia gravis
by: Isogai N, et al.
Published: (2012) -
Current and emerging therapies for the treatment of myasthenia gravis
by: Renato Mantegazza, et al.
Published: (2011)